RT Journal Article SR Electronic T1 Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP PA2085 DO 10.1183/13993003.congress-2016.PA2085 VO 48 IS suppl 60 A1 Ivan Cherrez Ojeda A1 Vincent Cottin A1 Juan Calderon A1 Erick Calero A1 Dayana Cabrera A1 Annia Cherrez A1 Jose Martin Vilema YR 2016 UL http://erj.ersjournals.com/content/48/suppl_60/PA2085.abstract AB Introduction: Idiopathic pulmonary fibrosis (IPF) consists of chronic, progressive decline in lung function. Clinical manifestations and course are unpredictable. An European survey about management of IPF suggested that community respiratory physicians may need further education.Aim: To evaluate the current practice patterns and attitudes of general physicians (GPs) and specialists in the diagnosis and management of patients with IPF in Latin-America.Methods: Observational, descriptive, cross sectional study. We used the original AIR 2013 survey consisted of 28 questions about clinical management of patients with IPF, which was translated to Spanish using a rigorous methodology. Questions related to attitudes towards management of IPF were included. Descriptive statistics were used accordingly. X2 was used for comparisons.Results: 70 physicians were enrolled. 91.3% considered the guidelines relevant, the use of corticosteroids was reported by 46.2% of pneumologist and 28% of GPs. Otherwise, corticosteroids+immunotherapy was used by 7.7% of pneumologist and 8% of GPs and similar use of N-acetylcysteine (7.7% and 4%, p<0.05). Pirfenidone, which plays an important role in the therapy for mild to moderate IPF was only used by 15.4% of pneumologist. We found that only 54.3% felt confident on their knowledge of IPF. We found also that only 3.4% of physicians use DLCO in order to identify the progression of the disease, and 42.4% use FVC (52.8% of pneumologist and 32% of GPs). Both are essential to recognize a progression. 55.6% never had access to multidisciplinary team.Conclusion: Despite consciousness of international IPF guidelines, management of IPF in Latin-America needs to be improved.